Works matching IS 03407004 AND DT 2005 AND VI 54 AND IP 11

Results: 10

Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1137, doi. 10.1007/s00262-005-0703-4

By:

Sinha, Pratima;
Clements, Virginia K.;
Miller, Seth;
Ostrand-Rosenberg, Suzanne

Publication type:

Article

T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1043, doi. 10.1007/s00262-005-0681-6

By:

Schetelig, Johannes;
Kiani, Alexander;
Schmitz, Marc;
Ehninger, Gerhard;
Bornh&äuser, Martin

Publication type:

Article

Tumor counterattack: fact or fiction?

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1127, doi. 10.1007/s00262-005-0680-7

By:

Igney, Frederik H.;
Krammer, Peter H.

Publication type:

Article

Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1106, doi. 10.1007/s00262-005-0696-z

By:

Guo Xiaoling;
Liu Ying;
Liu Jing;
Li Huifang;
Zhu Xia;
Fan Qingqing;
Zhu Ping

Publication type:

Article

Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1095, doi. 10.1007/s00262-005-0701-6

By:

Cragun, William Chad;
Yamshchikov, Galina V.;
Bissonette, Eric A.;
Smolkin, Mark E.;
Eastham, Shannon;
Petroni, Gina R.;
Schrecengost, Randy S.;
Woodson, Elizabeth M. H.;
Slingluff Jr., Craig L.

Publication type:

Article

The interplay between innate and adaptive immunity regulates cancer development.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1143, doi. 10.1007/s00262-005-0702-5

By:

de Visser, K. E.;
Coussens, L. M.

Publication type:

Article

CD3 × CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1059, doi. 10.1007/s00262-005-0671-8

By:

Willems, An;
Schoonooghe, Steve;
Eeckhout, Dominique;
De Jaeger, Geert;
Grooten, Johan;
Mertens, Nico

Publication type:

Article

Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1115, doi. 10.1007/s00262-005-0698-x

By:

Hui Li;
Cao, Ming Y.;
Yoon Lee;
Lee, Vivian;
Ningping Feng;
Benatar, Tania;
Hongnan Jin;
Ming Wang;
Der, Sandy;
Wright, Jim A.;
Young, Aiping H.

Publication type:

Article

Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1072, doi. 10.1007/s00262-005-0670-9

By:

Albers, Andreas E.;
Ferris, Robert L.;
Kim, Grace G.;
Chikamatsu, Kazuaki;
DeLeo, Albert B.;
Whiteside, Theresa L.

Publication type:

Article

Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine.

Published in:

Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1082, doi. 10.1007/s00262-005-0687-0

By:

Marshall, Deborah J.;
San Mateo, Lani R.;
Rudnick, Kelly A.;
McCarthy, Stephen G.;
Harris, Michael C.;
McCauley, Christine;
Schantz, Allen;
Dong Geng;
Cawood, Pam;
Snyder, Linda A.

Publication type:

Article